Eton seeks FDA expansion of hydrocortisone liquid for children under 5
Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA to expand the label of its KHINDIVI oral solution to include pediatric adrenal insufficiency patients under five years old. A new formulation of KHINDIVI demonstrated bioequivalence to an FDA-approved hydrocortisone granule formulation, potentially …
ETON
main company
Sharemaestro market context
Trend signal active
52 weeks +240.2% · Next-week setup positive 57.2%